Related Experiment Video

Updated: Jun 14, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

306

CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting

Qi Liu1, Mingyuan Song1, Yan Wang2

  • 1Department of Thyroid Surgery, The First Hospital of China Medical University, Shenyang, China.

Biochimica Et Biophysica Acta. Reviews on Cancer
|May 10, 2025
PubMed

Insights

Chemokine CCL20 and its receptor CCR6 play key roles in cancer progression within the tumor microenvironment. Targeting this axis offers promising immunotherapeutic strategies for various cancers.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Chemokine CC motif ligand 20 (CCL20) is an immunomodulatory molecule implicated in inflammation, autoimmune diseases, and cancer.
  • CCL20 exerts its functions by binding to its receptor, CC chemokine receptor type 6 (CCR6), initiating intracellular signaling cascades.

Purpose of the Study:

  • To review the biological effects of CCL20-CCR6 signaling.
  • To elucidate the role and mechanisms of the CCL20-CCR6 axis in the tumor microenvironment (TME).
  • To explore the potential applications of targeting this axis in cancer therapy.

Main Methods:

  • Literature review summarizing existing research on CCL20 and CCR6.
  • Analysis of studies investigating the CCL20-CCR6 axis in various cancer types.
  • Examination of therapeutic strategies targeting the CCL20-CCR6 pathway.

Main Results:

  • The CCL20-CCR6 axis is crucial for regulating immune responses within the TME.
  • Monoclonal antibodies against CCL20 and CCR6 inhibitors have been developed to block signaling.
  • This axis significantly influences cancer progression and immune evasion.

Conclusions:

  • The CCL20-CCR6 axis is a critical regulator in the tumor microenvironment with significant implications for cancer.
  • Targeting this axis presents a promising avenue for cancer immunotherapy.
  • The CCL20-CCR6 axis may serve as a novel biomarker for cancer diagnosis and prognosis.
Keywords:
CCL20CCR6ChemokineImmunosuppressionImmunotherapyTumor microenvironment

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.4K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K